dpp 4 inhibitor and glp 1 agonist DPP-4 inhibitors GLP-1RAs: cardiovascular safety and benefits fig2.gif

When administered s.c., liraglutide fails to inhibit eating in mice possessing a CNS-specific deletion of GLP-1R [688]

Patients should be incredibly careful about where their treatment is coming from to ensure they are receiving safe, regulated medication

Assessing the efficacy and safety of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor (AZD4017) in the idiopathic intracranial hypertension drug trial, IIH: DT: clinical methods and design for a phase II randomized controlled trial

doi: 10.4239/wjd.v1.i1.8

This means AUD is not just a disease of the brain, but the gut may be involved too

PLoS One, 10 , e0139709